Effects of Vitamin D Supplementation on Glucose Metabolism in Women With Former Gestational Diabetes Mellitus
Launched by RCSI & UCD MALAYSIA CAMPUS · Nov 18, 2013
Trial Information
Current as of June 21, 2025
Completed
Keywords
ClinConnect Summary
Gestational diabetes mellitus (GDM) is a state of glucose intolerance occurring during pregnancy and is related to both resistance to peripheral action of insulin and impairment of beta (β)-cell function. Its transient presence during pregnancy alerts to a heightened risk of diabetes in the future. About 10-50% of women with GDM develop diabetes mellitus later on in life. Data from Malaysia found that 50% of GDM women had developed diabetes at an interval of five to seven years post index pregnancy. Therefore, it is paramount that the investigators identify effective measures to prevent dia...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women with Gestational Diabetes (GDM) on the most recent pregnancy- between 6 and 48 months post partum at time of recruitment to study
- • Previous GDM defined as-Fasting plasma glucose ≥ 7.0 mmol/l or 2-h plasma glucose ≥ 7.8 mmol/l on 75g OGTT performed during gestation OR As determined by treating physician during index pregnancy
- • With no plan to conceive again within the 6 months of study duration
- • With 75g OGTT at study baseline confirming either Normal respond, Impaired Fasting Glucose (IFG) or Impaired Glucose Tolerance (IGT)
- • Vitamin D deficiency at baseline - defined as Plasma 25-(OH) D concentration of between 15 and 50nmol/L
- Exclusion Criteria:
- • Pregnancy or Breast feeding
About Rcsi & Ucd Malaysia Campus
RCSI & UCD Malaysia Campus is a prestigious institution focused on advancing medical education and research. As a collaborative entity between the Royal College of Surgeons in Ireland and University College Dublin, the campus is dedicated to fostering innovative clinical trials that enhance healthcare outcomes. With a commitment to excellence in research and a multidisciplinary approach, RCSI & UCD Malaysia Campus aims to contribute significantly to the global medical community by addressing pressing health challenges through rigorous scientific inquiry and ethical standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Penang, , Malaysia
Patients applied
Trial Officials
Toh Peng Yeow, MB BCH BAO, FRCP(Edin)
Principal Investigator
Penang Medical College, 4 Jalan Sepoy Lines, 11450, Penang, Malaysia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials